Homeopathic medicinal products: an Update

Similar documents
New Frontiers in the Quality of Medicines

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) POINTS TO CONSIDER ON THE JUSTIFICATION OF HOMEOPATHIC USE

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) DRAFT (12/08) POINTS TO CONSIDER ON STABILITY TESTING OF HOMEOPATHIC MEDICINAL PRODUCTS

Guide. homoeopathic preparations. for the elaboration of monographs on

GUIDE TO REGISTER HOMEOPATHIC PRODUCTS FOR VETERINARY USE

General Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe

Update regarding PSUR and RMP for herbal and homeopathical medicinal products

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG)

Pharmakon drug Poiea to make Government of each country List of Pharmacopeias: British European Indian International United state.

European Medicines Agency Evaluation of Medicines for Human Use COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL

EDQM and European Pharmacopoeia: State-of-the-art Science for Tomorrow s Medicines

Regulation of Herbal and Traditional Medicines in Germany BfArM in Dialogue - TradReg 2017

General concepts in the Ph. Eur.: theory and rationale

Particular challenges of evaluation of herbal combination products

Ensuring protection of public health and patients in member states: priorities, constraints, opportunities

Discussion by HMPC Drafting Group on Quality February Start of public consultation 27 June 2012

Guideline on the use of the CTD format in the preparation of a registration application for traditional herbal medicinal products 1

SUMMARY MINUTES. of the BRITISH PHARMACOPOEIA COMMISSION

DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 31 March 2004

QUALITY OF HERBAL MEDICINAL PRODUCTS: PRESENT REQUIREMENTS

Topics covered by the talk

Guide to Registration of Homeopathic Veterinary Medicinal Products

The International Pharmacopoeia - Overview

REGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011.

DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) DRAFT COMMUNITY HERBAL MONOGRAPH ON VALERIANA OFFICINALIS L., RADIX AND HUMULUS LUPULUS L.

Guideline on quality of herbal medicinal products 2 /traditional herbal medicinal products

Food additives. FAO guidelines on the structure and content of the document called "Chemical and Technical Assessment (CTA)" Rome, February 2003

State Pharmacopoeia of Ukraine

Public Assessment Report for a Homeopathic Medicinal Product for Human Use

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON SOLIDAGO VIRGAUREA L., HERBA

FOOD AND DRUGS AUTHORITY (FDA) GHANA

EMEA WORKING PARTY ON HERBAL MEDICINAL PRODUCTS

QUALITY OF HERBAL REMEDIES

Dormeasan, oral drops, solution (Valeriana officinalis L., radix, tincture; Humulus lupulus L., strobulus, tincture)

Public Assessment Report for a Homeopathic Medicinal Product for Human Use

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015

Obstacles in Assessment and Licensing of Medicinal Products from Asian Traditional Medicines in Europe PD Dr. Werner Knöss BfArM

HMPWG - Questions and Answers on First safe Dilutions

Comparison of the requirements in the registration and marketing. authorisation procedure of human homoeopathic medicinal products within

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

IPEC Europe Suggested Alternative (if none then original text is clear and needs no alteration) Purpose and Scope

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON ECHINACEA PALLIDA (NUTT.) NUTT., RADIX

SUBMISSION FOR RECLASSIFICATION

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON ALTHAEA OFFICINALIS L., RADIX

Discussion by HMPC Drafting Group on Quality September Start of public consultation 15 February 2013

Public Assessment Report. Scientific discussion. Pentasa Compact 4 g, prolonged-release granules. (mesalazine) NL License RVG:

Guideline on quality of herbal medicinal products 1 /traditional herbal medicinal products

Feed Additive Approval An Industry View. Dr Heidi Burrows Regulatory manager

by presentations in Rome (2004), Amsterdam and Strasbourg (2005).

Guideline on the use of the CTD format in the preparation of a registration application for traditional herbal medicinal products 1

Comparative Studies on Pharmacopoeial Definitions, Requirements and Information for Crude Drugs among FHH Member Countries in 2007

European Medicines Agency. Superseded COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON SALVIA OFFICINALIS L.

Public Assessment Report Scientific discussion. Lamotrigin Medartuum Lamotrigine SE/H/728/01-04/MR

Requirements to the Registration of Medicinal products in the Republic of Armenia

This Administrative regulation will come into force on 1 st August 2013 and will remain so until further notice.

Discussion at the HMPC January March Draft agreed by Quality Working Party April Adoption by CHMP for release for consultation 26 May 2005

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON PASSIFLORA INCARNATA L., HERBA

This Administrative regulation will come into force on 1 st January 2018 and will remain so until further notice. Administrative Regulation No 3/2015

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

SUBMISSION FOR RECLASSIFICATION

SUBMISSION FOR RECLASSIFICATION

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) DRAFT COMMUNITY HERBAL MONOGRAPH ON THYMUS VULGARIS L. AND THYMUS ZYGIS L., HERBA

AD HOC WORKING GROUP ON HERBAL MEDICINAL PRODUCTS

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) DRAFT COMMUNITY HERBAL MONOGRAPH ON EQUISETUM ARVENSE L., HERBA

Guideline on quality aspects on the isolation of candidate influenza vaccine viruses in cell culture

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL PROCEDURE FOR THE PREPARATION OF COMMUNITY MONOGRAPHS FOR TRADITIONAL HERBAL MEDICINAL PRODUCTS

Updated work programme of the European Pharmacopoeia

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) DRAFT COMMUNITY HERBAL MONOGRAPH ON MELILOTUS OFFICINALIS (L.) LAM., HERBA

The European Union CD 1999/83/EEC on well-established use

H e r b a l M e dicines' Q U A L I T Y M ANUAL. I. Introduction

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON HAMAMELIS VIRGINIANA L., FOLIUM

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON AVENA SATIVA L., HERBA

Recognized Pharmacopoeia in Registration system

Public Assessment Report for a Homeopathic Medicinal Product for Human Use

European Medicines Agency Inspections

The State Pharmacopoeia of the Russian Federation

Medicinal Products for Human Use HOMEOPATHIC MEDCINAL PRODUCT FOR HUMAN USE. December 2005

BRITISH PHARMACOPOEIA COMMISSION. Expert Advisory Group ULM: Unlicensed Medicines SUMMARY MINUTES

European Medicines Agency Evaluation of Medicines for Human Use. Superseded COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL

Workshop for OIE national Focal Points for Veterinary Products November 2010, Johannesburg, South Africa. Presentation

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) DRAFT COMMUNITY HERBAL MONOGRAPH ON RUSCUS ACULEATUS L., RHIZOMA

Scientific and Regulatory Basis for Development, Quality Assurance and Marketing Authorisation

European Medicines Agency Evaluation of Medicines for Human Use. Superseded COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL

EUROPEAN PHARMACOPOEIA: TACKLING FUTURE CHALLENGES OF THE QUALITY OF MEDICINES TOGETHER

BRITISH PHARMACOPOEIA COMMISSION EXPERT ADVISORY GROUP (EAG): MEDICINAL CHEMICALS 1 (MC1) SUMMARY MINUTES

Excipient Risk Assessment

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

E (FAD ; CRL/140034)

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL

EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON DISINTEGRATION TEST GENERAL CHAPTER Q4B ANNEX 5(R1)

NOTICE TO APPLICANTS

Draft Guideline on Pharmaceutical Development of Medicines for Paediatric Use. C. Nopitsch-Mai London 1

Paper Style University Exam, BHMS Programme FIRST BHMS Subject: Homoeopathic Pharmacy. Section 1

Organisations and/or individuals

European Union legislation on Food additives, Food enzymes, Extractions solvents and Food flavourings

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) DRAFT COMMUNITY HERBAL MONOGRAPH ON BETULA PENDULA ROTH; BETULA PUBESCENS EHRH.

BRITISH PHARMACOPOEIA COMMISSION EXPERT ADVISORY GROUP: MEDICINAL CHEMICALS 3 SUMMARY MINUTES

Transcription:

Homeopathic medicinal products: an Update Mag. Dr. Astrid Obmann Expert Group Herbal Medicinal Products & Homeopathics AGES-Gespräch Homeopathics: an Update Vienna, 12.5.2015 www.basg.gv.at Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH Overview News from the Homeopathic Medicinal Products Working Group () News from the EDQM - Homoeopathic Raw Materials and Stocks () - Homoeopathic Manufacturing Methods Working Party (HMM WP) News from the German Homoeopathic Pharmacopoeia (GHP/HAB) 2 Working group of the HMA Dedicated to homeopathic medicinal products for human and veterinary use Representatives from the NCAs + Veterinarian http://www.hma.eu/hmpwg.html 3 1

Last Meeting: 4.-5.12.2014 Rome - Interesting Topics: oelection of a new chair o Interpretation of the term administered externally in the context of registrations according to Art. 14 of Dir 2001/83/EC as amended o Justification of homeopathic use oimpact of heat treatment on stocks o First safe dilutions o Viral safety o Subworking group on quality o Microbiological quality Next Meeting: 28.-29.5.2015 Strasbourg 4 Election of a new chair - Biancamaria Bruno (IT) Interpretation of the term administered externally in the context of Art. 14 registrations - Request of the European Commission - Definition to be included in the NtA - Draft Letter to EC Justification of Homeopathic Use - Second List of stocks adopted - Discussion on nomenclature ( Titles used in homoeopathy, Pharmeuropa 16.4) 5 Impact of heat treatment on stocks - Outcome of discussion: Safety first First safe dilutions - Assessment is a complex procedure - Limited resources in member states - Existing process should be improved, each member state should contribute - Comments from public consultation to be discussed in the sub working group 6 2

Viral safety - Revision of the Points to consider on Safety of Homeopathic Medicinal Products from biological origin - Public consultation until 10.4.2015 - Overview of comments to be presented at the next -Meeting Sub working group on quality - First discussion - Chair? 7 Microbiological quality - How should limits given in Ph. Eur. be applied to raw material, stocks, dilutions and finished product? - Presentation of a draft-decision tree - Next meeting: first draft on points to consider to be presented 8 Working party of the EDQM Development of individual Ph. Eur. monographs for homeopathic raw materials and stocks So far 24 monographs included (Ph. Eur. 8.5) Very slow progress due to complex procedure and extensive discussions So far priority list only for potentially toxic preparations 9 3

New Monographs (Ph. Eur. 8.3) - Homoeopathic pillules, coated (2786) - Agaricus phalloides for homoeopathic preparations (2290) - Ignatia for homoeopathic preparations (2513) - Nux-vomica for homoeopathic preparations (2514) 10 Points for discussions - Assay: o Mandatory for potentially toxic herbal substances, e.g. Nux-vomica for homoeopathic preparations (2514) o Non-toxic substances? E.g. Allium sativum for homoeopathic preparations (2023) 11 Nomenclature - From Standard Ph. Eur. wording back to Traditional homoeopathic names - e.g Allium sativum - AT: Nomenclature according to currently valid GHP- Monographs 12 4

Structure of the monographs changes - e.g. Nux-vomica for homoeopathic preparations o Identification: Microscopic examination (Test B) with illustrations o Mother tinctures: more detailed description of production methods compared to older monographs 13 Outlook - Priority list for non-toxic preparations o Survey among Member States ( Most important preparations ) - General Monograph on minerals for homoeopathic use shall be added to work programme 14 HMM WP Working party of the EDQM Development and improvement of the monograph Methods of preparation of homoeopathic stocks and potentisation - Methods from German Homoeopathic Pharmacopoeia and French Pharmacopoeia to be integrated in Ph. Eur. Development and improvement of other general monographs 15 5

HMM WP Current work programme - Integration of GHP methods 21 + 22 - Microbiological quality (Ph. Eur. 5.1.4, 5.1.8) o See planned Points to consider - Revision: o Homoeopathic pillules, impregnated (2079) o Methods of preparation of homoeopathic stocks and potentisation (2371) 16 GHP 2014 New texts - Monographs o Amanita muscaria o Humulus lupulus ferm 34d - Other texts oreagents o Raw material Revised texts - Monographs (e.g. Bryonia) o Omission of wet chemical analysis for identification o In general identification preferably by TLC o Addition of an assay (preferably by HPLC) 17 GHP 2014 Revised texts - Methods of preparation (Method 21, 22, 28) o Precision of wording - Reagents - Carriers and excipients o Yeast : change of storage conditions Corrected texts - Only monographs - In most cases editorial changes 18 6